PRINZI, NATALIE
 Distribuzione geografica
Continente #
NA - Nord America 1.131
EU - Europa 401
AS - Asia 163
AF - Africa 11
SA - Sud America 9
OC - Oceania 1
Totale 1.716
Nazione #
US - Stati Uniti d'America 1.128
IT - Italia 199
SE - Svezia 66
DE - Germania 52
CN - Cina 51
SG - Singapore 47
IN - India 45
FI - Finlandia 24
GB - Regno Unito 13
HK - Hong Kong 11
TG - Togo 10
FR - Francia 8
AR - Argentina 7
RO - Romania 7
UA - Ucraina 7
BG - Bulgaria 6
RU - Federazione Russa 5
IE - Irlanda 4
MY - Malesia 4
NL - Olanda 4
AL - Albania 2
CA - Canada 2
ES - Italia 2
PT - Portogallo 2
AU - Australia 1
CL - Cile 1
IR - Iran 1
KZ - Kazakistan 1
LK - Sri Lanka 1
PA - Panama 1
PY - Paraguay 1
TR - Turchia 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 1.716
Città #
Fairfield 175
Ashburn 131
Chandler 128
Woodbridge 79
Seattle 78
Wilmington 68
Cambridge 60
Rome 59
Houston 58
Singapore 30
Beijing 29
Princeton 28
Ann Arbor 22
Plano 22
Lawrence 20
San Paolo di Civitate 20
Dearborn 18
Millbury 17
Milan 13
San Diego 12
Washington 12
Central 11
Lomé 10
Boston 9
Florence 9
New York 9
Feltham 8
Turin 8
Federal 7
Andover 6
Bühl 6
Des Moines 6
Sofia 6
Helsinki 5
Nanjing 5
Naples 5
Redwood City 5
Amsterdam 4
Bologna 4
Dublin 4
Norwalk 4
Padova 4
Santa Clara 4
Bremen 3
Buffalo 3
Kunming 3
Los Angeles 3
Mannheim 3
Phoenix 3
Springfield 3
Busto Arsizio 2
Falls Church 2
Fremont 2
Giugliano in Campania 2
Guangzhou 2
Hefei 2
Lafayette 2
London 2
Manfredonia 2
Munich 2
Nanchang 2
Palo del Colle 2
Pavia 2
Portici 2
Racale 2
San Mateo 2
Siena 2
Simi Valley 2
Toronto 2
Trecastelli 2
Almaty 1
Asunción 1
Baotou 1
Bellusco 1
Bergamo 1
Castel Volturno 1
Catania 1
Chicago 1
Colombo 1
Copertino 1
Corchiano 1
Dallas 1
Delhi 1
Dreieich 1
Falkenstein 1
Fiuggi 1
Formia 1
Grafing 1
Istanbul 1
Jacksonville 1
Jinan 1
Lisbon 1
Livorno 1
Martellago 1
Modderfontein 1
Mumbai 1
Nuremberg 1
Nâves-parmelan 1
Ostuni 1
Ozzano dell'Emilia 1
Totale 1.309
Nome #
Alterata espressione dei geni coinvolti nel processo di sumoilazione nel carcinoma papillare della tiroide. 140
Association of thyroid diseases with primary extra-thyroidal malignancies in women. Results of a cross-sectional study of 6,386 patients 122
Grey-scale analysis improves the ultrasonographic evaluation of thyroid nodules 99
Thyroid autoantibodies and breast cancer 98
Deregulated expression of Aurora kinases is not a prognostic biomarker in papillary thyroid cancer patients 96
New molecular approaches in the diagnosis and prognosis of thyroid cancer patients 89
Preclinical testing of selective Aurora kinase inhibitors on a medullary thyroid carcinoma-derived cell line 82
Consumption of iodized salt may not represent a reliable indicator of iodine adequacy. Evidence from a cross-sectional study on schoolchildren living in an urban area of central Italy 79
Prevalence of breast cancer in thyroid diseases. Results of a cross-sectional study of 3,921 patients 77
Emerging molecular markers for the prognosis of differentiated thyroid cancer patients 74
Selective inhibitors of aurora kinases inhibit proliferation, reduce cell viability and impair cell cycle progression in papillary thyroid carcinoma cells 73
Rationale and protocol of MetNET-2 trial: Lanreotide Autogel plus metformin in advanced gastrointestinal or lung neuroendocrine tumors 70
Correlation between fertility drugs use and malignant melanoma incidence: the state of the art 70
Subcutaneous metastases from colon cancer: A case report 69
Fertility drugs, reproductive strategies and ovarian cancer risk 66
Update on medical treatment of small intestinal neuroendocrine tumors 63
Effects of selective inhibitors of Aurora kinases on anaplastic thyroid carcinoma cell lines 63
Primary cerebellar neuroendocrine tumors: chimeras or real entities? A case report with a 6-year follow-up 62
Nutritional status and follicular-derived thyroid cancer. An update 57
Peptide receptor radionuclide therapy: focus on bronchial neuroendocrine tumors 57
Ability of selective small molecule inhibitors of Aurora-A and Aurora-B in inhibiting tumorigenicity of anaplastic thyroid carcinoma-derived cell lines. 49
Expected and paradoxical effects of obesity on cancer treatment response 49
The dual Aurora kinase inhibitor ZM447439 prevents anaplastic thyroid cancer cell growth and tumorigenicity 45
Surgical strategies in patients with medullary thyroid carcinoma 39
Gender-related differences in patients with carcinoid syndrome: new insights from an Italian multicenter cohort study 18
Totale 1.806
Categoria #
all - tutte 4.728
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.728


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020329 0 0 2 17 34 47 64 50 50 34 19 12
2020/2021144 14 19 7 2 19 18 14 6 11 20 10 4
2021/2022281 10 11 23 20 33 13 6 20 26 21 44 54
2022/2023361 52 94 23 34 32 40 6 25 30 4 15 6
2023/2024255 14 22 19 7 24 75 15 9 5 38 16 11
2024/202556 28 10 18 0 0 0 0 0 0 0 0 0
Totale 1.806